P497 Injection site reactions and injection site pain for the adalimumab biosimilar ABP 501: Results from two double-blind, randomised, controlled studies | Zendy

AI Assistant Blog Pricing

P497 Injection site reactions and injection site pain for the adalimumab biosimilar ABP 501: Results from two double-blind, randomised, controlled studies

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.